throbber
International Union of Microbiological Societies
`
`Developments
`in
`Biological Standardization
`Vol. 74
`
`Edited by
`the
`International Association of Biological Standardization
`
`Acting Editors
`Joan C. May (Bethesda, MD) — F. Brown (Guildford)
`
`@ MARGE
`
`Basel ¢ Miinchen ® Paris © London ¢ New York ® New Delhi © Singapore ® Tokyo ¢ Sydney
`
`Mylan Exhibit 1126
`Mylan v. Regeneron, IPR2021-00880
`Page 1
`
`Mylan Exhibit 1126
`Mylan v. Regeneron, IPR2021-00880
`Page 1
`
`

`

`IV
`
`Bibliographic Indices
`This publication is listed in bibliographic services, including Current Contents® and Index Medicus.
`
`Drug Dosage
`The authors and the publisher have exerted every effort to ensure that drug selection and dosageset
`forth in this text are in accord with current recommendationsand practice at the time of publication.
`However, in view of ongoing research, changes in government regulations, and the constant flow of
`informationrelating to drug therapy and drugreactions, the readeris urged to check the packageinsert
`for each drug for any changein indications and dosage and for added warningsandprecautions. This
`is particularly important when the recommendedagentis a new and/orinfrequently employed drug.
`
`All rights reserved
`No partofthis publication may betranslated into other languages, reproducedorutilized in any form
`or by any means,electronic or mechanical, including photocopying, recording, microcopying, or by
`any information storage and retrieval system, without permission in writing from the publisher.
`
`© Copyright 1992 by S. Karger AG, P.O. Box, CH-4009 Basel (Switzerland).
`Printed in Switzerland by Médecine et Hygiéne, Genéve.
`
`ISBN 3-8055-5466-4
`
`Mylan Exhibit 1126
`Mylan v. Regeneron, IPR2021-00880
`Page 2
`
`Mylan Exhibit 1126
`Mylan v. Regeneron, IPR2021-00880
`Page 2
`
`

`

`This material may be protected by Copyright law (Title 17 U.S. Code)
`
`Mylan Exhibit 1126
`Mylan v. Regeneron, IPR2021-00880
`Page 3
`
`

`

`74
`
`D.B. Volkin and A.M. Klibanov
`
`Reversible thermal denaturation
`
`The native, catalytically active conformation of a protein is maintained by a
`delicate balance of noncovalent forces including hydrogen bonds, hydrophobic,
`ionic and van der Waals interactions. An increase in temperature affects the
`strength of these interactions to different extents, thereby distorting this delicate
`balance and causing protein molecules to unfold. Upon cooling, the non-covalent
`interactions return to theirinitial state, and the enzymeregainsits native, catalyti-
`cally active conformation. This reversibility stems from the «thermodynamic
`hypothesis» which states that the native conformation of a protein in a given
`environmentcorresponds to the minimum free energy of the entire system. This
`conformation is determined by the amino acid sequence. The thermodynamic
`hypothesis is based on the classic experiments of Anfinsen and coworkers who
`demonstrated that ribonuclease, once reduced and unfolded in urea, can refold
`into the native, catalytically active structure by removal of urea and re-oxidation
`of sulfhydryl groups (2).
`The reversible unfolding of proteins has been examined extensively andits
`mechanisms are well understood (3). The design of protein formulations fre-
`quently utilizes additives and solvents whichstabilize proteins against reversible
`denaturation (4). The reversible partial unfolding of a protein is usually the first
`step, subsequently followed by conformational or covalent processesin irreversi-
`ble thermo-inactivation.
`
`Irreversible thermal inactivation of proteins
`
`If a protein solution is heated and then rapidly cooled, but full catalytic
`activity is not recovered within a reasonable time, then the protein has undergone
`irreversible thermalinactivation. In this case, conformational or chemical changes
`(see below) have occurred whicheither prevent refolding or destroy the integrity
`of the polypeptide molecule.
`
`1. Aggregation
`
`Heat-induced protein aggregation is most commonly described as a two-step
`process. First, as the temperature rises, the conformational flexibility (« breath-
`ing») of a protein intensifies until eventually conformational changes (local
`changes in secondary andtertiary structure) or reversible protein denaturation
`(cooperative loss of higher ordered structure) take place. This partially exposes the
`buried, interior hydrophobic aminoacid residues to the aqueoussolvent. In the
`second stage of this process, the thermally altered protein molecules associate
`intermolecularly (primarily via hydrophobicinteractions) in order to minimize the
`unfavorable exposure of hydrophobic amino acid residues to water (5). Subse-
`quent chemical reactions mayalso occur,especially intermolecular disulfide cross-
`links (6).
`
`2. Mechanisms of protein thermo-inactivation
`
`Intermolecular aggregation can be circumvented by employingdilute protein
`solutions or by using immobilized enzymes (7). As a result,
`the actual.
`monomolecular processes that cause irreversible thermal inactivation of enzymes
`can be determined. In order to elucidate their mechanisms, the relative contribu-
`
`Mylan Exhibit 1126
`Mylan v. Regeneron, IPR2021-00880
`Page 4
`
`Mylan Exhibit 1126
`Mylan v. Regeneron, IPR2021-00880
`Page 4
`
`

`

`Protein structure changes and inactivation
`
`75
`
`tions of conformational and covalent reactionsto the overall thermo-inactivation
`pathway must be determined.
`A monomolecular model for irreversible conformational thermal inactivation
`was proposed based on studies with immobilized trypsin (8). At high tempera-
`tures, an enzymelosesits native non-covalent (intramolecular) interactions; sub-
`sequently, non-native interactions may form which, although thermodynamically
`unfavorable, remain for purely kinetic reasons so that the protein cannot spon-
`taneously refold to the native conformation at ambient temperatures.
`Twoseparate criteria were established to identify monomolecular conforma-
`tional inactivation. First, enzymes can be reactivated after thermo-inactivation
`has occurred. For example, immobilized trypsin was heated and rapidly cooled
`(losing virtually all enzymatic activity), then completely unfolded and reducedin
`urea, and subsequently re-oxidized in the absence of denaturant. Recovery of
`enzymatic activity was nearly complete, implying that immobilized trypsin inacti-
`vated almostentirely via incorrect structure formation (8). A second methodology
`to measureirreversible conformational inactivation is based on the difference
`between the rates of thermo-inactivation in the presence and absenceofreversible
`denaturants (9).
`;
`11) quantitatively
`Employing these two strategies,
`some authors (10,
`accounted for the processes causingirreversible thermal inactivation (pH range of
`4-8) of hen egg-white lysozyme at 100°C and bovine pancreatic ribonuclease A at
`90°C,respectively. First, the overall monomolecularrate constantsofirreversible
`thermal inactivation were determined for both enzymes (protein concentrations
`wereselected so that no aggregation occurred), as shownin thefirst line of Table
`I. Second, a comparison of the rate constants of thermo-inactivation in the
`presence and absence of denaturants, along with reactivation experiments via the
`method described above for immobilized trypsin, provided the rate constant of
`incorrect structure formation, as shown in Table I. In the case of ribonuclease,
`these incorrect structures were foundto stem from thethiol-catalysed interchange
`of disulfide bonds (see next section).
`Samples of thermally inactivated lysozyme and ribonuclease were also ana-
`lysed for peptide chain integrity and aminoacid destruction to identify deleterious
`covalent processes that contribute to inactivation. As can be seen in Table I, the
`degradative covalent changes in the primary structure of lysozyme and
`ribonuclease are pH-dependentreactions whoserelative contribution to irreversi-
`ble thermo-inactivation consequently varies with pH. The general nature of these
`covalentreactionsis discussed in the next section. These degradative reactions not
`only pointed to « weak links» in the primarystructure of proteins, but also helped
`to define the upper limit of protein thermostability.
`
`Hydrolysis ofpeptide bonds at aspartic acid residues
`
`In the case of both ribonuclease and lysozyme,the hydrolysis of the polypep-
`tide chain at the carboxyl terminus of aspartic acid at acidic pHs was shown to
`proceed at rates comparable to thermo-inactivation. A combination of SDSpoly-
`acrylamide gel electrophoresis and gel scanning densitometry was used,along with
`measurements of the appearance of new carboxy and aminotermini. By examin-
`ing a series of Asp-X peptides, it has been shown(12) that the Asp-Pro bondis
`particularly labile at high temperatures under acidic conditions. Replacement of
`
`Mylan Exhibit 1126
`Mylan v. Regeneron, IPR2021-00880
`Page 5
`
`Mylan Exhibit 1126
`Mylan v. Regeneron, IPR2021-00880
`Page 5
`
`

`

`76
`
`D.B. Volkin and A.M. Klibanov
`
`Table I. The rate constantsofirreversible thermo-inactivation of lysozyme and ribonuclease: the over-
`all process and contributions of individual mechanisms to thermo-inactivation (14).
`
`Irreversible thermo-inactivation
`of two model proteins
`
`
`
`Rate constants (hr~!)
`
`H6
`ae +
`
`
`
`
`
`Hen egg white lysozyme, 100°C (10)
`Directly measured overall process
`Dueto individual mechanisms:
`Deamidation of Asn/Gln residues
`Hydrolysis of Asp-X peptide bonds
`Destruction of cystine residues
`Formation ofincorrect structures
`
`H
`
`4.1
`
`Bovine pancreatic ribonuclease 90°C (11)
`Directly measured overall process
`Due to individual mechanisms:
`Deamidation of Asn/Gln residues
`Hydrolysis of Asp-x peptide bonds
`Destruction of cystine residues
`Formation ofincorrect structures'
`
`'
`
`Shownto be dueto thiol-catalysed disulfide interchange.
`
`such labile Asp residues by meansofsite-directed mutagenesiscan greatly stabilize
`proteins (13).
`
`Deamidation of asparagine and glutamine residues
`
`Deamidation of asparagine and/or glutamineresidues was found to contribute
`to the irreversible thermo-inactivation of both ribonuclease and lysozyme. The
`rate of ammonia release from thermo-inactivated enzyme was determined by
`either chemical or enzymatic methods. Moreover, since deamidation converts Asn
`to Asp and Gln to Glu, the extent of deamidation was further characterized by
`isoelectric focusing (IEF) coupled with quantitative gel scanning. By extraction of
`deamidated species from the IEFgel, it was found that each random deamidation,
`on average, lowers the specifc activity by 30-50% compared to the native enzyme
`(14).
`An in-depth investigation into the nature of the deamidation reaction in three
`model hexapeptides containing asparagine residues confirmed that the mechanism
`of deamidation underneutral to basic conditions involves an intramolecularcycli-
`zation (15). The main chain amide nitrogen acts as a nucleophile attacking the
`electrophilic asparagine amide causing ring closure to the imide with concomitant
`release of ammonia. The subsequent hydrolysis leads to a mixture of « and B
`aspartyl residues. A temperature and sequence dependence of deamidation in”
`model hexapeptides at 100°C at pH 7.4 was observed. It was found that Asn-Gly
`is 30-50 times morelabile than Asn-Pro and Asn-Leu duetosteric factors.
`
`Mylan Exhibit 1126
`Mylan v. Regeneron, IPR2021-00880
`Page 6
`
`Mylan Exhibit 1126
`Mylan v. Regeneron, IPR2021-00880
`Page 6
`
`

`

`Protein structure changes andinactivation
`
`77
`
`Recent studies have shownthatthe tertiary structure ofa protein is a principal
`‘determinant to deamidation under physiological conditions. By using neutron
`diffraction techniques, the time-aged, deamidatedprotein crystals of trypsin were
`examinedandthesites of deamidation did not correlate with the previously men-
`tioned peptide studies (16). Moreover,kinetic studies on the deamidation ofa par-
`ticularly labile Asn-Gly sequence in ribonuclease showedsignificantly (30-fold)
`increased lability in the unfolded versus folded enzyme(17).
`Asexpected from the cyclic imide mechanism,the rate of heat-induced deami-
`dation in ribonuclease and lysozymeincreased as the pH wasraised from 4 to 8
`(see Table I). Heat-induced deamidation seems to be a general phenomenon as
`seen by the continuous release of ammonia (levelling off at the total number of
`Asn and Gin residues) in 10 different globular proteins heated at pH 4 and 100°C
`(Volkin and Klibanov, unpublished results). In a practical application of this
`knowledge,site-directed mutagenesis has been used to removespecific asparagine
`residues from the dimer interface of triose phosphate isomerase. The resulting
`mutant enzyme showed a two fold increasein stability against irreversible thermo-
`inactivation (18). A similar approach has been Seinen applied to recom-
`binant interleukin-lo (19).
`
`Cystine destruction and thiol-catalysed disulfide interchange
`Amino acid analysis revealed the destruction of cystine residues during the
`thermo-inactivation of ribonuclease and lysozymeat neutralto slightly alkaline
`pH. The loss of disulfide bonds occurred at rates comparable to thermo-
`inactivation. By identifying the by-products of cystine destruction, this process
`was shown to proceed via a {-elimination reaction to yield dehydroalanine,
`thiocysteine and lysinoalanine residues (20).
`Other workers (11) demonstrated that the disulfide bonds of ribonuclease are
`reshuffled during irreversible thermo-inactivation. Not only was the enzymestabi-
`lized against irreversible thermo-inactivation by adding thiol scavengers such as
`copperchloride, but heating in the presenceoffree-labelled cystine resulted in the
`incorporation of its fragments into the enzymevia a mixed disulfide. In a thiol-
`catalysed disulfide interchange reaction, free thiols carry out nucleophilic attack
`on the sulfur atom of a disulfide (21).
`The generality of the heat lability of disulfide bonds in over a dozen proteins
`(containing between 1 and 19 cystine residues) at 100°C wasinvestigated (22). The
`B-elimination reaction was shownto generatefree thiols which in turn catalyse dis-
`ulfide interchange.
`
`Oxidation of cysteine residues
`
`By first quantitatively determining the mechanisms of irreversible thermo-
`inactivation for two model enzymes(ribonuclease and lysozyme), it was then pos-
`sible to study thermo-inactivation of more complicated enzyme systems. Some
`researchers (23, 24) examined the thermostability of several homologousbacterial
`a-amylases. The thermal
`inactivation of both mesophilic and thermophilic
`enzymes at 90°C and pH 6.5 was due to a monomolecular conformational
`process. The differences in thermostability between mesophilic and thermophilic
`enzyme were shownto be dueto additional salt bridges in the latter. When the
`conformationalinactivation process was suppressed (by additives or pH changes),
`
`Mylan Exhibit 1126
`Mylan v. Regeneron, IPR2021-00880
`Page 7
`
`Mylan Exhibit 1126
`Mylan v. Regeneron, IPR2021-00880
`Page 7
`
`

`

`78
`
`D.B. Volkin and A.M. Klibanov
`
`a-amylase underwentirreversible thermo-inactivation (at 90°C) via deamidation
`of its asparagine and/or glutamine residues and oxidation of cysteine residues.
`Similarly, in the case of immobilized glucose isomerase, conformational scram-
`bling (in the absence of substrate), deamidation of Asn and/or Gln residues
`(90°C) and cysteine oxidation (70°C) were shown to contribute to thermo-
`inactivation (25).
`Cysteine residues undergo auto-oxidation to form intra- or intermoleculardis-
`ulfide bondsor oxidation products such as sulfenic acid (21). These oxidative reac-
`tions are catalysed by divalent metal ions (especially copper) with enhancedrates
`at elevated pH. The productsof cysteine oxidation during the thermo-inactivation
`of «-amylase were determined to be 30%sulfenic acid and 70% new disulfides
`(23).
`
`CONCLUSIONS
`
`Recombinant DNAtechnology allows us to manufacture humanproteins for
`use as therapeutic agents. Consequently, the pharmaceutical scientist must now
`develop rational strategies to stabilize these proteinsin vitro. It is necessary to pre-
`pare formulations of proteins that will be stable under defined storage conditions
`for periods exceeding one year. A critical step toward developing such stabilized
`preparations is an understanding of the causes and mechanisms of temperature
`induced-inactivation, which can be subsequently extrapolated to ambient condi-
`tions.
`Upto this point, we have discussed the degradative pathways, both conforma-
`tional and covalent, that contribute to the loss of enzymatic activity during heat-
`ing in aqueoussolution. Environmental conditions can bealtered in a variety of
`ways (temperature, pH, salts, solvents, etc.) to cause protein inactivation (26).
`Similar to thermo-inactivation, these environmental changes usually induce
`partial unfolding or disruption of the tertiary structure,
`thereby exposing
`hydrophobicor chemically labile residues which leads to conformationalor cova-
`lent inactivation. Although the pathwaysare similar, additional «weak links»in
`the primary structure have been identified: oxidation of methionine residues,
`racemization of aspartic acid and serine residues, photodegradation of trypto-
`phan, and nucleophilic addition reactions involving lysine residues (26).
`The freezing and lyophilization of a protein solution mayalso lead to inactiva-
`tion, since both processes involve the concentration of solutes as wateris crystal-
`lized and sublimated, respectively. As water moleculescrystallize during freezing,
`solutes such as salts and protein molecules are concentrated, causing potentially
`significant shifts in pH and ionic strength. These shifts may cause conformational
`changesin a protein leading to aggregation. For example, the freezing of an iso-
`tonic saline solution (0.15M) to — 21°C causes a 24-fold increasein salt concentra-
`tion. Moreover, the pH of a sodium phosphate buffer can shift several pH units
`upon freezing (27). Another potential mechanism of protein inactivation during
`freezing is oxidation; the oxygen concentrationin a partially frozen system at -3°C
`is 1150-fold higher than that solution at 0°C (28).
`The subsequentstorage of lyophilized proteins can be accompaniedbyinacti--
`vation. Recent workin our laboratory has shownthat as lyophilized protein pow-
`ders are hydrated during storage, the protein molecules may aggregate in the solid
`
`Mylan Exhibit 1126
`Mylan v. Regeneron, IPR2021-00880
`Page 8
`
`Mylan Exhibit 1126
`Mylan v. Regeneron, IPR2021-00880
`Page 8
`
`

`

`Protein structure changes and inactivation
`
`79
`
`state, thereby losing the ability to dissolve in aqueous solution upon addition of
`water. In the case of lyophilized BSA, as well as several other proteins, this loss
`of solubility was shownto be dueto a thiol-disulfide interchange reaction. When
`the free cysteine residue of BSA was alkylated, and then freeze-dried and stored
`in a humid atmosphereas before,the solubility of the protein powder upon recon-
`stitution was dramatically increased (29).
`In summary, an understanding of causes and mechanismsofprotein inactiva-
`tion allows for the developmentof rational strategies (both protein engineering
`and formulation design) to minimize, or perhaps even eliminate, its occurrence.
`
`REFERENCES
`
`. Lumry, R. and Eyring, H. (1954). Conformational changes of proteins. Journal of Physical
`Chemistry 58, 110-120.
`. Anfinsen, C.B. and Scheraga, H.A. (1975). Experimental and theoretical aspects of protein fold-
`ing. Advances in Protein Chemistry 29, 205-301.
`. Lapanje, S. (1978). Physicochemical Aspects of Protein Denaturation. Wiley, New York.
`4. Timasheff, S.N. and Arakawa, T. (1989). Stabilization of protein structure by solvents. In:
`Protein structure: a practical approach (T.E. Creighton, ed.) pp. 283-289, IRL Press, Oxford.
`. Jaenicke, R. (1967). Intermolecular forces in the process of heat aggregation of globular proteins
`and the problem of correlation between aggregation and denaturation phenomena. Journal of
`Polymer Science Part C 16, 2143-2160.
`. Mozhaev, V.V. and Martinek, K. (1982). Inactivation and reactivation of proteins (enzymes).
`Enzyme and Microbial Technology 4, 299-309.
`. Klibanov, A.M. (1983). Stabilization of enzymes against thermal inactivation. Advances in
`Applied Microbiology 29, 1-28.
`(1978). On the mechanism of irreversible thermo-
`. Klibanov, A.M. and Mozhaev, V.V.
`inactivation of enzymes andpossibilities for reactivation of «irreversibly» inactivated enzymes.
`Biochemical and Biophysical Research Communications 83, 1012-1014.
`. Ahern, T.J. and Klibanov, A.M. (1986). Why do enzymesirreversibly inactivate at high tempera-
`tures? In: Protein structure. Folding and design (D.L. Oxender, ed.) pp. 283-289, Alan R. Liss,
`New York.
`Ahern, T.J. and Klibanov, A.M. (1985). The mechanism ofirreversible enzymeinactivation at
`100°C. Science 228, 1280-1284.
`Zale, S.E. and Klibanov, A.M. (1986). Why does ribonucleaseirreversibly inactivate at high tem-
`peratures? Biochemistry 25, 5432-5444.
`Marcus, F. (1985). Preferential cleavage at Asp-Pro peptide bondsin dilute acid. /nternational
`Journal of Peptide and Protein Research 25, 542-546.
`George-Nascimento, C., Lowenson, J., Borissenko, M., Calderon, M., Medina-Selby, A., Kuo,
`J., Clarke, S. and Randolph, A. (1990). Replacementoflabile aspartyl residue increasesthe stabil-
`ity of human epidermal growth factor. Biochemistry 29, 9584-9591.
`Ahern, T.J. and Klibanov, A.M. (1988). Analysis of processes causing thermalinactivation of
`enzymes. Methods in Biochemical Analysis 33, 91-127.
`Geiger, T. and Clarke, S. (1987). Deamidation, isomerization, and racemization at asparaginyl
`and aspartyl residues in proteins. Journal of Biological Chemistry 262, 785-794.
`Kossiakoff, A.A. (1988). Tertiary structure is a principal determinant to protein deamidation.
`Science 240, 191-194.
`Wearne,S.J. and Creighton, T.E. (1989). Effect of protein conformation on rate of deamidation:
`ribonuclease. A. Proteins, Structure, Function and Genetics 5, 8-12.
`Ahern, T.J., Casal, J.I., Petsko, G.A. and Klibanov, A.M. (1987). Control of oligomeric enzyme
`thermostability by protein engineering. Proceedings of the National Academy of Sciences USA
`84, 675-679.
`
`10.
`
`11.
`
`12.
`
`13.
`
`14,
`
`15.
`
`16.
`
`17.
`
`18.
`
`Mylan Exhibit 1126
`Mylan v. Regeneron, IPR2021-00880
`Page 9
`
`Mylan Exhibit 1126
`Mylan v. Regeneron, IPR2021-00880
`Page 9
`
`

`

`80
`
`D.B. Volkin and A.M. Klibanov
`
`19. Wingfield, P.T., Mattaliano, R.J., MacDonald, H.R., Craig, S., Clore, G.M., Gronenborn,
`A.M. and Schmeissner, U.
`(1987). Recombinant-derived interleukin-l« stabilized against a
`specific deamidation. Protein Engineering 1, 413-417.
`20. Whitaker, J.R. and Feeney, R.E. (1983). Chemical and physical modification of proteins by the
`hydroxide ion. CRC Critical Reviews in Food Science and Nutrition 19, 173-212.
`21. Torchinsky, Y.M. (1981). Sulfur in Proteins. Pergamon Press, Oxford.
`22. Volkin, D.B. and Klibanov, A.M. (1987). Thermal destruction processesin proteins involving cys-
`tine residues. Journal of Biological Chemistry 262, 2945-2950.
`23. Tomazic, S.J. and Klibanov, A.M. (1988a). Mechanismsofirreversible thermal inactivation of
`Bacillus «-amylases. Journal of Biological Chemistry 263, 3086-3091.
`24. Tomazic, S.J. and Klibanov, A.M. (1988b). Whyis one Bacillus «-amylase moreresistant against
`irreversible thermo-inactivation than another? Journal of Biological Chemistry 263, 3092-3096.
`25. Volkin, D.B. and Klibanov, A.M. (1989a). Mechanism of thermo-inactivation of immobilized
`glucose isomerase. Biotechnology and Bioengineering 33, 1104-1111.
`26. Volkin, D.B. and Klibanov, A.M. (1989b). Minimizing protein inactivation. In: Protein function:
`a practical approach (T.E. Creighton, ed.) pp. 1-124, Oxford Press, Oxford.
`27. Franks, F. (1990). Freeze-drying: from empiricism to predictability. Cryoletters 11, 93-110.
`28. Schwimmer,S. (1981). Source Book of Food Enzymology. Avi Publishing, Westport.
`29. Liu, W.R., Langer, R. and Klibanov, A.M. (1991). Moisture-induced aggregation of lyophilized
`proteins in the solid state. Biotechnology and Bioengineering 37, in press.
`
`GENERAL DISCUSSION
`
`PARTICIPANT:You showedin yourlast slide that you could, by alkylating
`and blocking the SH group explain the three microliters. But without blocking the
`SH group youdid get non-aggregation with seven microliters. How do youlink
`those two observations?
`S
`VOLKIN:I haveto confess that wasn’t my work,butI think that they carried
`it out at 7.5 microliters and it also blocked. This was just one example.
`YIM:I have two questions. You seem to indicate that the thermal inactivation
`whichis due to unfolding and a covalent and non-covalent inactivation seem to
`be additive with respect to inactivation. I think that might just be a very fortui-
`tious situation because percent of inactivation is not necessarily correlated with
`percentage of deamidation or anything like that.
`VOLKIN:Thereare manypossible chemical reactions that can cause inactiva-
`tion. These wereactually shownto causeinactivation. In the case of lysozyme and
`deamidation isoelectric focusing was carried out. The protein, the mono-, di-,
`trideaminated species were extracted from the gel, refolded, and the specific
`activity of each one was determined, and the decrease in activity was measured.
`YIM: This necessitates a linear correlation with percentage of inactivation
`versus percentage of deamination or oxidation.
`VOLKIN:Youare saying what if there is a deamidation on the surface, for
`instance, and that we wouldn’t expect to cause inactivation as much as deamida-
`tion of the interior residue. That certainly could be the case. These experiments
`were carried out at high temperatures where the protein is unfolded. So those
`residues are exposed.
`YIM: Doyouhave any data at lower temperatures so that one can extrapolate
`to more reasonable temperatures?
`
`v
`
`Mylan Exhibit 1126
`Mylan v. Regeneron, IPR2021-00880
`Page 10
`
`Mylan Exhibit 1126
`Mylan v. Regeneron, IPR2021-00880
`Page 10
`
`

`

`Protein structure changes and inactivation
`
`81
`
`VOLKIN:As wehave already heard, extrapolation is a very dangerous game.
`It‘is especially dangerousin these kinds of processes becauseit is not a linear rela-
`tionship because there are conformational effects. For instance, deamidation,
`whereat high temperatures we cansee certain patterns in peptide studies, we no
`longer see those patterns at low temperatures where the protein is folded. Soitis
`a very dangerous game to extrapolate lower. We werecarrying out these studies
`to look at the upper limit of protein thermostability to try to determine the weak
`links that limit protein stability.
`
`Mylan Exhibit 1126
`Mylan v. Regeneron, IPR2021-00880
`Page 11
`
`Mylan Exhibit 1126
`Mylan v. Regeneron, IPR2021-00880
`Page 11
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket